a University of Würzburg, Institute for Molecular Infection Biology , Josef-Schneider-Straße 2 D15, Würzburg.
Virulence. 2018 Dec 31;9(1):943-945. doi: 10.1080/21505594.2018.1425072.
In vivo imaging technologies offer a great potential for the diagnosis of difficult-to-treat bacterial infections. A major limitation of conventional imaging modalities is the lack of specificity to distinguish the site of bacterial infection from sterile inflammation. Targeted approaches like antibiotics linked to imaging tracers for detection of various bacterial pathogens or species-specific antibodies combined with anatomical imaging modalities are currently being evaluated to overcome this problem. Considering the recent progress in optical and targeted imaging that may accelerate preclinical development programs, clinical implementation of in vivo imaging modalities to detect bacterial infection foci becomes realistic in the future.
体内成像技术为治疗困难细菌感染的诊断提供了巨大的潜力。传统成像方式的一个主要限制是缺乏特异性,无法区分细菌感染部位和无菌性炎症。目前正在评估靶向方法,如与用于检测各种细菌病原体的成像示踪剂结合的抗生素,或与解剖成像方式相结合的针对特定物种的抗体,以克服这一问题。鉴于光学和靶向成像的最新进展可能会加速临床前开发计划,因此未来利用体内成像技术来检测细菌感染病灶在临床上成为现实。